CD274 and neoplasm: These findings suggest that PD-L1 induces an immune-suppressive macrophage phenotype while treatment with anti-PD-L1 antibody reverses macrophage polarization, thereby triggering a potent macrophage-mediated anti-tumor immune response (Hartley et al., 2018).